Close

Amarin Corp. (AMRN) Reports New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. NFLX
5. CSX
6. UAL
7. ALK
8. EFX
9. TSLA
10. INFY


Go back to Amarin Corp. (AMRN) Reports New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction

Northland Capital Markets Downgrades Amarin Corporation (AMRN) to Market Perform

May 4, 2022 3:27 PM EDT

Northland Capital Markets analyst Carl Byrnes downgraded Amarin Corporation (NASDAQ: AMRN) from Outperform to Market Perform with a price target of $2.00 (from $9.00).

The analyst comments "We are lowering our rating to MP from OP with a price target of $2/share. US VASCEPA... More

Amarin Corporation (AMRN) PT Lowered to $9 at Cowen

May 4, 2022 12:55 PM EDT

Cowen analyst Ken Cacciatore lowered the price target on Amarin Corporation (NASDAQ: AMRN) to $9.00 (from $10.00) while maintaining an Outperform rating.

The analyst commented, "Q1 sales were $94MM, coming in well below the Street. We continue to question the ongoing... More